SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-010439
Filing Date
2023-03-29
Accepted
2023-03-29 08:08:58
Documents
13
Period of Report
2023-03-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20230328.htm   iXBRL 8-K 64062
2 EX-99.1 crsp-ex99_1.htm EX-99 12671
  Complete submission text file 0000950170-23-010439.txt   193998

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20230328.xsd EX-101.SCH 2464
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20230328_pre.xml EX-101.PRE 10524
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20230328_lab.xml EX-101.LAB 12743
7 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20230328_htm.xml XML 4500
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 23771825
SIC: 2836 Biological Products, (No Diagnostic Substances)